Neuropace Share Price Today
(NASDAQ: NPCE)

Name: Neuropace Share Price Today (NASDAQ: NPCE) - Neuropace Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Neuropace share price is $10.79 & ₹922.17 as on 18 Apr 2025, 2.30 'hrs' IST

$10.79

▲

0.36

(3.45%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Neuropace share price in Dollar and Rupees. Guide to invest in Neuropace stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neuropace, along with analyst recommendations, forecasts, and comprehensive financials.

Neuropace share price movements

Today's Low: $10.25
Today's High: $10.89
$10.79
5.0%
Downside
Day's Volatility :5.83%
Upside
0.87%
52 Weeks Low: $5.45
52 Weeks High: $15.11
$10.79
49.49%
Downside
52 Weeks Volatility :63.93%
Upside
28.59%

Neuropace (NPCE) Returns

Period	Neuropace Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.38%	-2.8%	0.0%
6 Months	74.03%	-11.0%	0.0%
1 Year	-22.82%	-1.9%	0.0%
3 Years	29.22%	-1.5%	-12.9%

Neuropace (NPCE) Key Statistics

in dollars & INR

Previous Close	$10.43
Open	$10.42
Today's High	$10.885
Today's Low	$10.25
Market Capitalization	$351.3M
Today's Volume	$173.1K
52 Week High	$15.11
52 Week Low	$5.45
Revenue TTM	$79.9M
EBITDA	$-21.5M
Earnings Per Share (EPS)	$-0.96
Profit Margin	-33.97%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-189.35%

How to invest in Neuropace Stock (NPCE) from India?

It is very easy for Indian residents to invest directly in Neuropace from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neuropace stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neuropace or NPCE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neuropace or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neuropace shares which would translate to 0.079 fractional shares of Neuropace as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neuropace, in just a few clicks!

Returns in Neuropace (NPCE) for Indian investors in Rupees

The Neuropace stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Neuropace investment value today

Current value as on today

₹79,523

Returns

₹20,477

(-20.48%)

Returns from Neuropace Stock

₹22,818 (-22.82%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Neuropace (NPCE)

25%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Neuropace Stock from India on INDmoney has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Neuropace

KCK Ltd
14.12%
Orbimed Advisors, LLC
9.13%
Morgan Stanley - Brokerage Accounts
6.68%
Soleus Capital Management, L.P.
6.52%
Kent Lake PR LLC
3.97%
Vanguard Group Inc
2.83%

Analyst Recommendation on Neuropace

Rating

Trend

Buy

84%Buy

15%Hold

0%Sell

Based on 13 Wall street analysts offering stock ratings for Neuropace(by analysts ranked 0 to 5 stars)

Analyst Forecast on Neuropace Stock (NPCE)

What analysts predicted

Upside of 56.23%

Target:

$16.86

Current:

$10.79

Insights on Neuropace Stock (Ticker Symbol: NPCE)

Price Movement
In the last 6 months, NPCE stock has moved up by 61.2%
Increasing Revenue
Revenue is up for the last 6 quarters, 16.42M → 21.46M (in $), with an average increase of 5.2% per quarter
Increasing Net Profit
Netprofit is up for the last 4 quarters, -8.92M → -5.25M (in $), with an average increase of 20.2% per quarter
NPCE vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 41.5% return, outperforming this stock by 66.9%
NPCE vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 108.3% return, outperforming this stock by 83.4%
Price to Sales
ForNPCE every $1 of sales, investors are willing to pay $3.9, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Neuropace Technicals Summary

Sell

Neutral

Buy

Neuropace is currently in a neutral trading position according to technical analysis indicators.

Neuropace (NPCE) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Neuropace Inc	-10.4%	74.03%	-22.82%	29.22%	-56.77%
Medtronic Plc	-9.34%	-9.26%	3.93%	-26.9%	-18.65%
Edwards Lifesciences Corp.	0.35%	2.11%	-16.77%	-44.23%	-4.46%
Boston Scientific Corp.	-6.17%	8.03%	41.27%	101.95%	155.36%
Stryker Corporation	-7.36%	-5.65%	6.47%	25.38%	87.58%
Abbott Laboratories	3.31%	11.96%	22.09%	6.8%	33.65%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Neuropace Inc	NA	NA	NA	-0.84	-1.89	-0.13	NA	0.27
Medtronic Plc	25.18	25.18	1.42	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	30.57	30.57	4.28	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	76.2	76.2	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	44.62	44.62	1.97	13.47	0.15	0.07	0.01	54.1
Abbott Laboratories	17.14	17.14	4.17	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Neuropace Inc	Buy	$339.6M	-56.77%	NA	-33.97%
Medtronic Plc	Buy	$106.1B	-18.65%	25.18	12.83%
Edwards Lifesciences Corp.	Buy	$41.9B	-4.46%	30.57	76.75%
Boston Scientific Corp.	Buy	$140.9B	155.36%	76.2	11.07%
Stryker Corporation	Buy	$132.3B	87.58%	44.62	13.25%
Abbott Laboratories	Buy	$227.2B	33.65%	17.14	31.89%

About Neuropace

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Organization	Neuropace
Employees	184
CEO	Mr. Joel D. Becker
Industry	Healthcare

Management People of Neuropace

Name	Title
Mr. Joel D. Becker	CEO, President & Director
Ms. Rebecca L. Kuhn	CFO and VP of Finance & Administration
Dr. Martha J. Morrell M.D.	Chief Medical Officer
Mr. Dylan St. John	Chief of Operations & Development
Ms. Leah Akin	General Counsel & Corporate Secretary
Ms. Kelley Nicholas	Vice President of Sales
Ms. Katie Keller	Vice President of Marketing
Ms. Amy Treadwell	Vice President of Human Resources

Important FAQs about investing in NPCE Stock from India :

What is Neuropace share price today?

Neuropace share price today stands at $10.79, Open: $10.42 ; Previous Close: $10.43 ; High: $10.89 ; Low: $10.25 ; 52 Week High: $15.11 ; 52 Week Low: $5.45.

The stock opens at $10.42, after a previous close of $10.43. The stock reached a daily high of $10.89 and a low of $10.25, with a 52-week high of $15.11 and a 52-week low of $5.45.

Can Indians buy Neuropace shares?

Yes, Indians can invest in the Neuropace (NPCE) from India.

With INDmoney, you can buy Neuropace at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Neuropace at zero transaction cost.

How can I buy Neuropace shares from India?

It is very easy to buy Neuropace from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neuropace (NPCE) be purchased?

Yes, you can buy fractional shares of Neuropace with INDmoney app.

What are the documents required to start investing in Neuropace stocks?

To start investing in Neuropace, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.